{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:52:39Z","timestamp":1791424359475,"version":"4.3.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005721","name":"Universitat Bielefeld","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cjco.2026.06.021","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:29:16Z","timestamp":1784302156000},"page":"1447-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pacemaker Dependency in Patients Undergoing Implantation of Dual-chamber Devices After Alcohol Septum Ablation: A Retrospective Analysis"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5256-1179","authenticated-orcid":false,"given":"Sophia Schulze","family":"Lammers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Lawin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lawrenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2026.06.021_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196612","article-title":"Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany---an analysis of over 5 million patients","volume":"13","author":"Husser","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cjco.2026.06.021_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/eurheartj\/4.suppl_F.93","article-title":"Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy","volume":"4(suppl_F)","author":"Kuhn","year":"1983","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.06.021_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","article-title":"Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy","volume":"346","author":"Sigwart","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2026.06.021_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jtcvs.2004.08.047","article-title":"Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score","volume":"129","author":"Ralph-Edwards","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjco.2026.06.021_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamacardio.2016.0252","article-title":"Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US Nationwide Inpatient Database, 2003-2011","volume":"1","author":"Kim","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjco.2026.06.021_bib6","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.06.021_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/eurheartj\/ehr013","article-title":"Controversies in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: alcohol septal ablation","volume":"32","author":"Fifer","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.06.021_bib8","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2007.02.056","article-title":"Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Lawrenz","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.06.021_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.repc.2023.04.010","article-title":"Permanent pacemaker implantation after alcoholic septal ablation induced complete heart block: long-term impact","volume":"43","author":"Grazina","year":"2024","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.cjco.2026.06.021_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ehjqcco\/qcy049","article-title":"Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: insights from the Euro-ASA registry","volume":"5","author":"Jensen","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjco.2026.06.021_bib11","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jcin.2022.06.034","article-title":"Outcomes of patients with hypertrophic obstructive cardiomyopathy and pacemaker implanted after alcohol septal ablation","volume":"15","author":"Veselka","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjco.2026.06.021_bib12","first-page":"1415","article-title":"Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy","volume":"29","author":"Veselka","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.06.021_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03667-0","article-title":"Permanent pacemaker dependency in patients with new left bundle branch block and new first degree atrioventricular block after transcatheter aortic valve implantation","volume":"11","author":"Hartrampf","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjco.2026.06.021_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001983","article-title":"Very low ventricular pacing rates can be achieved safely in a heterogeneous pacemaker population and provide clinical benefits: the CANadian Multi-Centre Randomised Study-Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial","volume":"4","author":"Thibault","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2026.06.021_bib15","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/eurheartj\/eht495","article-title":"Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population","volume":"35","author":"Veselka","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2026.06.021_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0735-1097(03)00623-5","article-title":"Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy","volume":"42","author":"Chang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.06.021_bib17","first-page":"393","article-title":"Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool","volume":"98","author":"Karimianpour","year":"2021","journal-title":"Cathet Cardiovasc Interv"},{"key":"10.1016\/j.cjco.2026.06.021_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00392-021-01847-6","article-title":"Alcohol-induced right bundle branch block is associated with a benign outcome in HOCM after alcohol septum ablation (ASA)","volume":"111","author":"Lawin","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cjco.2026.06.021_bib19","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s10840-023-01532-w","article-title":"Predictors of cardiovascular implantable electronic device dependence at long-term follow-up after alcohol septal ablation in hypertrophic cardiomyopathy patients","volume":"66","author":"Bode","year":"2023","journal-title":"J Interv Card Electrophysiol"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26003112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26003112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:26:03Z","timestamp":1791422763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X26003112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589790X26003112"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2026.06.021","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pacemaker Dependency in Patients Undergoing Implantation of Dual-chamber Devices After Alcohol Septum Ablation: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2026.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}